Reaction Details Report a problem with these data
Target
Integrase
Ligand
BDBM50527154
Substrate
n/a
Meas. Tech.
ChEMBL_1902393 (CHEMBL4404615)
Ki
90±n/a nM
Citation
 Li, G; Meanwell, NA; Krystal, MR; Langley, DR; Naidu, BN; Sivaprakasam, P; Lewis, H; Kish, K; Khan, JA; Ng, A; Trainor, GL; Cianci, C; Dicker, IB; Walker, MA; Lin, Z; Protack, T; Discotto, L; Jenkins, S; Gerritz, SW; Pendri, A Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors. J Med Chem 63:2620-2637 (2020) [PubMed]  Article 
Target
Name:
Integrase
Synonyms:
pol
Type:
PROTEIN
Mol. Mass.:
32203.43
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_106649
Residue:
288
Sequence:
FLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTVHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVIESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPVWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM50527154
Synonyms:
CHEMBL4454255
Type:
Small organic molecule
Emp. Form.:
C29H30FN3O4
Mol. Mass.:
503.5646
SMILES:
Cc1nc2cc(nn2c(-c2cc(F)c3OCCCc3c2C)c1[C@H](OC(C)(C)C)C(O)=O)-c1ccccc1 |r,wD:22.26,(14.1,-46.79,;12.76,-46.03,;11.43,-46.8,;10.09,-46.03,;8.63,-46.5,;7.72,-45.25,;8.63,-44.02,;10.09,-44.49,;11.42,-43.71,;11.41,-42.18,;12.75,-41.41,;12.74,-39.87,;14.07,-39.09,;11.4,-39.11,;11.39,-37.57,;10.05,-36.8,;8.72,-37.58,;8.72,-39.13,;10.07,-39.89,;10.08,-41.42,;8.75,-42.2,;12.76,-44.48,;14.09,-43.7,;14.08,-42.16,;15.41,-41.39,;15.41,-39.85,;16.75,-42.15,;16.74,-40.6,;15.43,-44.47,;16.76,-43.69,;15.43,-46.01,;6.18,-45.26,;5.42,-43.92,;3.88,-43.92,;3.1,-45.25,;3.88,-46.59,;5.42,-46.59,)|
Structure:
Search PDB for entries with ligand similarity: